Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Meyskens, FL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 51 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Keefe, KA; Schell, MJ; Brewer, C; McHale, M; Brewster, W; Chapman, JA; Rose, GS; McMeeken, DS; Lagerberg, W; Peng, YM; Wilczynski, SP; Anton-Culver, H; Meyskens, FL; Berman, ML
      A randomized, double blind, phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    2. Meyskens, FL; Farmer, P; Fruehauf, JP
      Redox regulation in human melanocytes and melanoma

      PIGMENT CELL RESEARCH
    3. Meyskens, FL; McNulty, SE; Buckmeier, JA; Tohidian, NB; Spillane, TJ; Kahlon, RS; Gonzalez, RI
      Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes

      FREE RADICAL BIOLOGY AND MEDICINE
    4. Doyle, KJ; McLaren, CE; Shanks, JE; Galus, CM; Meyskens, FL
      Effects of difluoromethylornithine chemoprevention on audiometry thresholds and otoacoustic emissions

      ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
    5. Klein, EA; Meyskens, FL
      Potential target populations and clinical models for testing chemopreventive agents

      UROLOGY
    6. Powell, IJ; Meyskens, FL
      African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials

      UROLOGY
    7. Follen, M; Meyskens, FL; Atkinson, EN; Schottenfeld, D
      Why most randomized phase II cervical cancer chemoprevention trials are uninformative: Lessons for the future

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    8. Simoneau, AR; Gerner, EW; Phung, M; McLaren, CE; Meyskens, FL
      alpha-Difluoromethylornithine and polyamine levels in the human prostate: Results of a phase IIa trial

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    9. Armstrong, WB; Kennedy, AR; Wan, XS; Taylor, TH; Nguyen, QA; Jensen, J; Thompson, W; Lagerberg, W; Meyskens, FL
      Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial

      CLINICAL CANCER RESEARCH
    10. Moinpour, CM; Triplett, JS; McKnight, B; Lovato, LC; Upchurch, C; Leichman, CG; Muggia, FM; Tanaka, L; James, WA; Lennard, M; Meyskens, FL
      Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial

      PSYCHO-ONCOLOGY
    11. Armstrong, WB; Kennedy, AR; Wan, XS; Atiba, J; McLaren, E; Meyskens, FL
      Single-dose administration of Bowman-Birk inhibitor concentrate in patients with oral leukoplakia

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    12. Meyskens, FL; Jungi, WF; Gerber, M; de Waard, F; Heidemann, E; Heim, ME; Joossens, JV; Salvini, S; Trichopoulou, A; Varela, G; Wolfram, G
      WHO consensus conference on diet and cancer

      EUROPEAN JOURNAL OF CANCER PREVENTION
    13. Meyskens, FL
      Cancer prevention in the year 2025: an anticipation

      EUROPEAN JOURNAL OF CANCER
    14. Meyskens, FL
      Cancer population genetics and tumour prevention: an unfulfilled paradigm

      EUROPEAN JOURNAL OF CANCER
    15. Meyskens, FL
      Criteria for implementation of large and multiagent clinical chemoprevention trials

      JOURNAL OF CELLULAR BIOCHEMISTRY
    16. Armstrong, WB; Meyskens, FL
      Chemoprevention of head and neck cancer

      OTOLARYNGOLOGY-HEAD AND NECK SURGERY
    17. Meyskens, FL
      Vitamin A analogue for breast cancer prevention: a grade of F or incomplete?

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    18. Sondak, VK; Liu, PY; Flaherty, LE; Fletcher, WS; Periman, P; Gandara, DR; Taylor, SA; Balcerzak, SP; Meyskens, FL
      A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group Study

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    19. Meyskens, FL; Gerner, EW
      Development of difluoromethylornithine (DFMO) as a chemoprevention agent

      CLINICAL CANCER RESEARCH
    20. Meyskens, FL; Buckmeier, JA; McNulty, SE; Tohidian, NB
      Activation of nuclear factor-kappa B in human metastatic melanoma cells and the effect of oxidative stress

      CLINICAL CANCER RESEARCH
    21. Wan, XS; Meyskens, FL; Armstrong, WB; Taylor, TH; Kennedy, AR
      Relationship between protease activity and neu oncogene expression in patients with oral leukoplakia treated with the Bowman Birk Inhibitor

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    22. Meyskens, FL
      Cancer chemoprevention: Progress and promise

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    23. MEYSKENS FL; BUCKMEIER JA; TOHIDIAN NB
      OXIDATIVE MODULATION OF NFKB IN METASTATIC MELANOMA

      Journal of investigative medicine
    24. GOODMAN GE; VALANIS B; MEYSKENS FL; WILLIAMS JH; METCH BJ; THORNQUIST MD; OMENN GS
      STRATEGIES FOR RECRUITMENT TO A POPULATION-BASED LUNG-CANCER PREVENTION TRIAL - THE CARET EXPERIENCE WITH HEAVY SMOKERS

      Cancer epidemiology, biomarkers & prevention
    25. MEYSKENS FL
      PRINCIPLES OF HUMAN CHEMOPREVENTION

      Hematology/oncology clinics of North America
    26. MEYSKENS FL; JACOBSON J; NGUYEN B; WEISS GR; GANDARA DR; MACDONALD J
      PHASE-II TRIAL OF ORAL BETA-ALL TRANS-RETINOIC ACID IN HEPATOCELLULAR-CARCINOMA (SWOG 9157)

      Investigational new drugs
    27. MEYSKENS FL; BUCKMEIER JA; TOHIDIAN NB
      DIFFERENTIAL EXPRESSION OF NFKB AND RESPONSE TO OXIDATIVE STRESS IN NORMAL HUMAN MELANOCYTES AND METASTATIC MELANOMA-CELLS

      Journal of investigative dermatology
    28. AHNEN DJ; FEIGL P; QUAN G; FENOGLIOPREISER C; LOVATO LC; BUNN PA; STEMMERMAN G; WELLS JD; MACDONALD JS; MEYSKENS FL
      KI-RAS MUTATION AND P53 OVEREXPRESSION PREDICT THE CLINICAL BEHAVIOR OF COLORECTAL-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Cancer research
    29. MOINPOUR CM; SAVAGE MJ; TROXEL A; LOVATO LC; EISENBERGER M; VEITH RW; HIGGINS B; SKEEL R; YEE M; BLUMENSTEIN BA; CRAWFORD ED; MEYSKENS FL
      QUALITY-OF-LIFE IN ADVANCED PROSTATE-CANCER - RESULTS OF A RANDOMIZEDTHERAPEUTIC TRIAL

      Journal of the National Cancer Institute
    30. MEYSKENS FL; GERNER EW; EMERSON S; PELOT D; DURBIN T; DOYLE K; LAGERBERG W
      EFFECT OF ALPHA-DIFLUOROMETHYLORNITHINE ON RECTAL MUCOSAL LEVELS OF POLYAMINES IN A RANDOMIZED, DOUBLE-BLINDED TRIAL FOR COLON-CANCER PREVENTION

      Journal of the National Cancer Institute
    31. MEYSKENS FL; VANCHAU H; TOHIDIAN N; BUCKMEIER J
      LUMINOL-ENHANCED CHEMILUMINESCENT RESPONSE OF HUMAN MELANOCYTES AND MELANOMA-CELLS TO HYDROGEN-PEROXIDE STRESS

      Pigment cell research
    32. MEYSKENS FL
      PROCEEDINGS OF THE 16TH INTERNATIONAL PIGMENT CELL CONFERENCE - INTRODUCTION

      Pigment cell research
    33. GORDON W; SIEGMUND K; STANISIC TH; MCKNIGHT B; HARRIS IT; CARROLL PR; PARADELO JC; MEYERS FJ; CHAPMAN RA; MEYSKENS FL
      A STUDY OF REPRODUCTIVE FUNCTION IN PATIENTS WITH SEMINOMA TREATED WITH RADIOTHERAPY AND ORCHIECTOMY - (SWOG-8711)

      International journal of radiation oncology, biology, physics
    34. STRICKLAND CJ; FEIGL P; UPCHURCH C; KING DK; PIERCE HI; GREVSTAD PK; BEARDEN JD; DAWSON M; LOEWEN WC; MEYSKENS FL
      IMPROVING BREAST SELF-EXAMINATION COMPLIANCE - A SOUTHWEST-ONCOLOGY-GROUP RANDOMIZED TRIAL OF 3 INTERVENTIONS

      Preventive medicine
    35. ATIBA JO; MEYSKENS FL; SCHELL MJ; ARMENTROUT SA; CHO J; WONG SF; NEAL J; RAMSINGHANI N
      ALL-TRANSRETINOIC ACID (ATRA) - A NEW AND EFFECTIVE SALVAGE AGENT FORRECURRENT HIGH-GRADE MALIGNANT GLIOMA (RHGMG)

      Journal of clinical oncology
    36. OMENN GS; GOODMAN GE; THORNQUIST MD; BALMES J; CULLEN MR; GLASS A; KEOGH JP; MEYSKENS FL; VALANIS B; WILLIAMS JH; BARNHART S; HAMMAR S
      EFFECTS OF A COMBINATION OF BETA-CAROTENE AND VITAMIN-A ON LUNG-CANCER AND CARDIOVASCULAR-DISEASE

      The New England journal of medicine
    37. OMENN GS; GOODMAN GE; THORNQUIST MD; BALMES J; CULLEN MR; GLASS A; KEOGH JP; MEYSKENS FL; VALANIS B; WILLIAMS JH; BARNHART S; CHERNIACK MG; BRODKIN CA; HAMMAR S
      RISK-FACTORS FOR LUNG-CANCER AND FOR INTERVENTION EFFECTS IN CARET, THE BETA-CAROTENE AND RETINOL EFFICACY TRIAL

      Journal of the National Cancer Institute
    38. SONDAK VK; KOPECKY KJ; MEYSKENS FL
      RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY -RESPONSE

      Journal of the National Cancer Institute
    39. MANZONE H; BILLINGS PC; CUMMINGS WN; FELDMAN R; CLARK LC; ODELL CS; HORAN AM; ATIBA JO; MEYSKENS FL; KENNEDY AR
      LEVELS OF PROTEOLYTIC ACTIVITIES AS INTERMEDIATE MARKER END-POINTS INORAL CARCINOGENESIS

      Cancer epidemiology, biomarkers & prevention
    40. CHILDERS JM; CHU J; VOIGT LF; FEIGL P; TAMIMI HK; FRANKLIN EW; ALBERTS DS; MEYSKENS FL
      CHEMOPREVENTION OF CERVICAL-CANCER WITH FOLIC-ACID - A PHASE-III SOUTHWEST-ONCOLOGY-GROUP INTERGROUP STUDY

      Cancer epidemiology, biomarkers & prevention
    41. MEYSKENS FL; GERNER EW
      DEVELOPMENT OF DIFLUOROMETHYLORNITHINE AS A CHEMOPREVENTION AGENT FORTHE MANAGEMENT OF COLON-CANCER

      Journal of cellular biochemistry
    42. MEYSKENS FL; KOPECKY KJ; APPELBAUM FR; BALCERZAK SP; SAMLOWSKI W; HYNES H
      EFFECTS OF VITAMIN-A ON SURVIVAL IN PATIENTS WITH CHRONIC MYELOGENOUSLEUKEMIA - A SWOG RANDOMIZED TRIAL

      Leukemia research
    43. TUTHILL RJ; RECTOR DJ; SONDAK VK; LIU PY; MEYSKENS FL
      TUMOR-INFILTRATING LYMPHOCYTES (TILS) IN STAGE-I CUTANEOUS MELANOMA -A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Laboratory investigation
    44. MEYSKENS FL; MANETTA A
      PREVENTION OF CERVICAL INTRAEPITHELIAL NEOPLASIA AND CERVICAL-CANCER

      The American journal of clinical nutrition
    45. MEYSKENS FL; KOPECKY KJ; TAYLOR CW; NOYES RD; TUTHILL RJ; HERSH EM; FEUN LG; DOROSHOW JH; FLAHERTY LE; SONDAK VK
      RANDOMIZED TRIAL OF ADJUVANT HUMAN INTERFERON-GAMMA VERSUS OBSERVATION IN HIGH-RISK CUTANEOUS MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of the National Cancer Institute
    46. YAMANISHI DT; MEYSKENS FL
      ALTERATIONS IN GENE-EXPRESSION AND SIGNAL TRANSDUCTIONS IN HUMAN MELANOCYTES AND MELANOMA-CELLS

      Critical reviews in oncogenesis
    47. MEYSKENS FL; LIU PY; TUTHILL RJ; SONDAK VK; FLETCHER WS; JEWELL WR; SAMLOWSKI W; BALCERZAK SP; RECTOR DJ; NOYES RD; COSTANZI JJ
      RANDOMIZED TRIAL OF VITAMIN-A VERSUS OBSERVATION AS ADJUVANT THERAPY IN HIGH-RISK PRIMARY MALIGNANT-MELANOMA - A SOUTHWEST-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    48. YAMANISHI DT; OHNO S; JAKOWATZ J; GOODMAN M; MEYSKENS FL
      ALTERATIONS IN THE EXPRESSION OF THE PROTEIN-KINASE-C ISOTYPES IN HUMAN CELL-LINES AND TISSUE BIOPSIES

      Journal of cellular biochemistry
    49. MEYSKENS FL; SURWIT E; MOON TE; CHILDERS JM; DAVIS JR; DORR RT; JOHNSON CS; ALBERTS DS
      ENHANCEMENT OF REGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA-II (MODERATE DYSPLASIA) WITH TOPICALLY APPLIED ALL-TRANS-RETINOIC ACID - A RANDOMIZED TRIAL

      Journal of the National Cancer Institute
    50. MEYSKENS FL; EMERSON SS; PELOT D; MESHKINPOUR H; SHASSETZ LR; EINSPAHR J; ALBERTS DS; GERNER EW
      DOSE DE-ESCALATION CHEMOPREVENTION TRIAL OF ALPHA-DIFLUOROMETHYLORNITHINE IN PATIENTS WITH COLON POLYPS

      Journal of the National Cancer Institute
    51. BACK SA; COLON M; FALLON JH; MEYSKENS FL; LOUGHLIN SE
      VENTRAL MESENCEPHALIC AND CORTICAL TRANSPLANTS INTO THE RAT STRIATUM DISPLAY ENHANCED ACTIVITY FOR NEUTRAL ENDOPEPTIDASE 24.11 (ENKEPHALINASE CALLA)

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/08/20 alle ore 16:36:12